Identification of the JAK2 V617F mutation is a major diagnostic criterion for the classical myeloproliferative neoplasms (MPN) of polycythemia vera, essential thrombocythemia and primary myelofibrosis. This evidence concerns the gene JAK2 and myeloproliferative disorder.